Kisspeptin-10 Side Effects: What Studies and Users Report
What FDA labels, clinical studies and people who use Kisspeptin-10 report, how strong that evidence is, and what is still unknown.
Side effects reported in studies
Side effects reported in published studies, strongest design first. Frequencies are quoted as the source gives them; animal results are labelled.
| Side effect | How common | Study type | Source |
|---|---|---|---|
| Pituitary hormone safety check“Mean serum GH, PRL and TSH did not change during the first 4 h following kisspeptin-54 injection when compared with vehicle.” | Frequency not stated | Human controlled trialn = 5 | Clinical endocrinology 2014, PMID 24863252 |
| Desensitisation (loss of response) on repeated dosing | 1 patient | Human uncontrolled trialn = 12 | Human reproduction 2019, PMID 31820802 |
| Injection-site oedema (mouse skin) | dose-dependent | Animal · mouse (CD1) (not a human result) | PloS one 2011, PMID 21347414 |
| Reduced skin blood flow / vasoconstriction (mouse)“Kp-10 was found to significantly reduce clearance, in keeping with decreased blood flow and providing further evidence for vasoconstrictor activity.” | Frequency not stated | Animal · mouse (CD1) (not a human result) | PloS one 2011, PMID 21347414 |
Overall safety findings
What studies said about safety as a whole, without naming a specific effect.
| Finding | How common | Study type | Source |
|---|---|---|---|
| Tolerability“Kisspeptin was well-tolerated with no reported adverse effects.” | Frequency not stated | Human RCTn = 40 | JAMA network open 2022, PMID 36287566 |
| Adverse effects“No adverse effects were observed.” | Frequency not stated | Human RCT | Clinical pharmacology and therapeutics 2010, PMID 20980998 |
What users report
Side effects people describe from their own use of Kisspeptin-10, quoted from 17 Reddit threads we read in r/Peptides (searched 11 Oct 2026). Each count is the number of different people in those threads, not how common the effect is. These reports are unverified: products bought outside a pharmacy are often mislabelled or impure, and many people take several compounds at once.
| What people noticed | People reporting it | In their words |
|---|---|---|
| Tiredness or lethargy | 3 | “Then followed by tiredness, kind of like a crash after taking a stimulant.” r/Peptides, Dec 2025“I just started and feel very sleepy took 200 mcg” r/Peptides, Dec 2024 |
| Feeling unwell | 2 | “Kisspeptin made me feel horrible from the first dose.” r/Peptides, Aug 2025“even more litle bit sick” r/Peptides, Dec 2024 |
| Low mood | 1 | “i am on day 3 feeling so down” r/Peptides, Dec 2024 |
| Irritability | 1 | “I seem to get more irritable and maybe warm/sweaty” r/Peptides, Dec 2025 |
1 person in the same threads said they noticed no side effects:
A symptom others mention is not proof that it is harmless. If you have anything on the urgent list below, get care whatever others report.
What is not known
- How common each effect is at the doses people use outside of studies.
- Effects that take longer to appear than the length of the published studies.
- How Kisspeptin-10 interacts with other medicines and supplements.
- Whether research-grade products, which are not checked by the FDA, behave like the material used in studies.
When to get medical help
This is not a complete list. A doctor or pharmacist can help you judge whether a symptom is related.
What kisspeptin trials say about tolerability
A trial in women with hypoactive sexual desire disorder reported that kisspeptin was well tolerated with no reported adverse effects.[1]
A study of twice-weekly kisspeptin-54 in women with hypothalamic amenorrhea reported that no adverse effects were observed.[3]
In two early trials of the kisspeptin-receptor agonist MVT-602, it was reported as safe and well tolerated across the entire dose range.[10]
Questions the trials raise
Animal studies suggest kisspeptin may also stimulate GH, prolactin and TSH secretion, with implications for safety; the authors say no previous study had investigated this in humans.[2]
In women with infertility due to hypothalamic amenorrhea, chronic kisspeptin administration led to desensitization of gonadotropin release.[11]
A review notes that native kisspeptin-54 can induce oocyte maturation in IVF treatment, including in women at high risk of ovarian hyperstimulation syndrome.[10]
Common questions
What are the side effects of Kisspeptin-10?
Studies we summarise reported pituitary hormone safety check, desensitisation (loss of response) on repeated dosing, injection-site oedema (mouse skin). The table on this page gives how often each happened and links each source.
What side effects do people who use Kisspeptin-10 report?
In the 17 Reddit threads we read (11 Oct 2026), people most often described tiredness or lethargy (3 people), feeling unwell (2 people), low mood (1 person). These are unverified personal reports, often from products of unknown purity, and the counts are not rates.
Is Kisspeptin-10 safe?
Its safety has not been established by an FDA review. Kisspeptin-10 is not FDA approved for any use. Research-chemical products are not checked for purity or dose.
Is Kisspeptin-10 banned in sport?
Yes. Prohibited by WADA (S2.2.1). Tested athletes should not use it.
Is kisspeptin safe?
One human trial abstract states that kisspeptin was well tolerated with no reported adverse effects.[1]
What are the side effects of kisspeptin injections?
One twice-weekly kisspeptin-54 study reports that no adverse effects were observed.[3]
More on Kisspeptin-10
Sources
- 1Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial.JAMA network open · 2022PMID 36287566Accessed 2 Oct 2026
- 2Acute and chronic effects of kisspeptin-54 administration on GH, prolactin and TSH secretion in healthy women.Clinical endocrinology · 2014PMID 24863252Accessed 2 Oct 2026
- 3Twice-weekly administration of kisspeptin-54 for 8 weeks stimulates release of reproductive hormones in women with hypothalamic amenorrhea.Clinical pharmacology and therapeutics · 2010PMID 20980998Accessed 2 Oct 2026
- 4Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome.Human reproduction (Oxford, England) · 2019PMID 31820802Accessed 11 Oct 2026
- 5The vasoactive potential of kisspeptin-10 in the peripheral vasculature.PloS one · 2011PMID 21347414Accessed 11 Oct 2026
- 6Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
- 7Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2024reddit.comAccessed 11 Oct 2026
- 8Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
- 9Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2024reddit.comAccessed 11 Oct 2026
- 10Endocrine profile of the kisspeptin receptor agonist MVT-602 in healthy premenopausal women with and without ovarian stimulation: results from 2 randomized, placebo-controlled clinical tricals.Fertility and sterility · 2024PMID 37925096Accessed 2 Oct 2026
- 11Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis.The Journal of clinical endocrinology and metabolism · 2009PMID 19820030Accessed 2 Oct 2026
Found an error? Report a correction.